1. Introduction
Since December 2019, the new corona virus disease (COVID-19) has rapidly invaded the world and caused serious respiratory complications and deaths. Consequently, this pandemic has weighed heavily on the health systems of nations on the one hand, and on the economies and lives of individuals and communities on the other hand especially with the recurrent appearance of variants of the virus in the absence of an effective treatment that could eradicate the disease. This crisis situation has pushed the rich countries to compete for the rapid invention of vaccines against COVID-19 to be able to stop the pandemic. Hence, taking up the challenge to develop new vaccines in a limited time through important investments in the pharmaceutical industry and the clinical trials that reached billions of dollars.
1- Chakraborty C.
- Sharma A.R.
- Bhattacharya M.
- Lee S.-S.
- Agoramoorthy G.
- et al.
COVID-19 vaccine: challenges in developing countries and India's initiatives.
Meanwhile, the vaccination against the corona virus was subject to great controversy at the international level questioning the effectiveness, the safety, and the security of the new quickly invented vaccines.
2- Al-Qerem W.A.
- Jarab A.S.
- et al.
COVID-19 vaccination acceptance and its associated factors among a middle eastern population.
Indeed, low acceptance rates of corona virus vaccination have been recorded in the Middle East, Russia, Africa and in several European countries such as Italy and France.
3COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates.
Morocco was among the first countries to provide vaccination for its citizens, prioritizing at the outset in accordance with the recommendations of the World Health Organization (WHO). The prioritized segments included health professionals, people with strategic functions, the elderly, people with comorbidities, and those suffering from chronic diseases.
4OPSFPLIMCOVID-19210008_fre.pdf ». Consulté le: 12 avril 2022. [En ligne]. Disponible sur.
Currently, Morocco has expanded the population eligible for vaccination against the corona virus to include pregnant women in their second trimester and those who are breastfeeding. This decision was taken in order to prevent and avoid the risks of pre-eclampsia, abortion, premature delivery, induced fetal death, hospitalization, and even intensive care unit services in the event that women contract the virus during their pregnancy.
5- Garg I.
- Shekhar R.
- Sheikh A.B.
- Pal S.
- et al.
COVID-19 vaccine in pregnant and lactating women: a review of existing evidence and practice guidelines.
The vaccination of this vulnerable category of the population against the corona virus was not addressed during the launch of the vaccination campaigns for reasons related to the safety, efficacy, and harmlessness of the new vaccines as they were excluded from clinical trials.
6- Craig A.M.
- Hughes B.L.
- Swamy G.K.
- et al.
Coronavirus disease 2019 vaccines in pregnancy.
Therefore, in the absence of sufficient results and the lack of evidence for the safe use of corona virus vaccines by this population, it was important to assess and describe the perceptions of these women regarding vaccination in order to inform decision makers about factors affecting adherence and reluctance to vaccination among this population. Hence, providing them with crucial information that can assist them further promote vaccination.
This article is a cross-sectional study that aims at investigating the rate of vaccination among Moroccan mothers who gave birth in the last two years along with assessing their reasons for accepting or refusing vaccination, as well as to explore the determinants of reluctance or adherence to vaccination among this population, and to investigate the intention towards vaccination among the unvaccinated.
2. Methods
2.1 Study type and population
This was a descriptive and cross-sectional study, conducted in the health centers of the Skhirat-Temara prefecture in Morocco among adult mothers who resided in the same prefecture and accompanied their children aged one to 24 months (who were born or were breastfed during the first three waves of the Covid-19 pandemic in Morocco) for vaccination or other care. The survey period was from October 2021 to January 2022.
2.2 Eligibility criteria
Only mothers aged 18 years and up and given consent to participate to the study were included. Those who refused to participate in the study were excluded.
2.3 Questionnaire and sample
The sample size required for the results of this survey to be representative was calculated using the following formula
7- Serhier Z.
- Bendahhou K.
- Ben Abdelaziz A.
- Bennani M.O.
- et al.
Methodological sheet n°1: how to calculate the size of a sample for an observational study?.
:
Where: n = sample size
z = 1.96 for a 95% confidence level
p = 0.5 (to our knowledge, no national study available to inform us on the prevalence of pregnant or lactating women vaccinated)
m = 0.05 (margin of sampling error tolerated).
However, our survey included 458 participants who completed a standardized questionnaire divided into two sections. The first section was used to provide information on demographics, socioeconomic and clinical characteristics (maternal age, marital status, education level, place of residence, maternal occupation, monthly household income, history of gestational diabetes, history of COVID-19, etc.), as well as the vaccination status of the participants during pregnancy and after delivery and the age of their last child. The second section provides information on perceptions and future intentions to adhere to vaccination among participants initially reported as unvaccinated.
2.4 Statistical analysis
Descriptive statistics and frequencies were computed for each variables of the questionnaire.
Univariate analysis was performed using the Chi-square test and Fisher's exact test according to the test conditions. The logistic regression analysis was performed to assess the independent effect of age, residence, couple's education level, monthly household income, medical coverage, age of last child, history of COVID-19, and previous gestational diabetes on vaccination against COVID-19.
The list of the explanatory variables was established according to the results of the univariate analysis. A difference was considered to be statistically significant if the p value was less than 0.05. The associations were expressed in odds ratio (OR) at a confidence interval of 95%. Data analysis was performed using the statistical software Jamovi 1.6.
Ethics approval
This study was conducted with the approval of the Ethics Committee for Biomedical Research, Faculty of Medicine and Pharmacy, Mohamed V University of Rabat, Morocco (ethical approval n° C68/20 issued on February 18, 2021).
All the Participants were provided with a briefing note explaining the purpose of the study, the interview process, the confidentiality of the data, and the utility of the study results. Subsequently, oral and written informed consent was obtained from the participants before the interview began.
4. Discussion
This current cross-sectional study aims at investigating women's practices and perceptions of COVID-19 vaccination during pregnancy and postpartum (up to 24 months), as well as assessing the predictive determinants of acceptance of vaccination.
In this study, all participants revealed that they avoided being vaccinated during their pregnancies even with the availability of the vaccines and the recommendations of the national scientific commission, which are in line with those of the international learned society in favor of vaccination of pregnant and breastfeeding women.
8- Rasmussen S.A.
- Jamieson D.J.
- et al.
Pregnancy, postpartum care, and COVID-19 vaccination in 2021.
,9Breastfeeding and COVID-19 vaccination: position statement of the Italian scientific societies.
This result was nil compared to those reported in studies conducted in United States, and the Saudi Arabia, where the prevalence rates of vaccination among pregnant women were 29.3%, 32.0% respectively.
10- Binger K.S.
- Cui Y.
- Tsaih S.-W.
- Palatnik A.
- et al.
Factors associated with receipt of COVID-19 immunization during pregnancy.
,11- Ghamri R.A.
- Othman S.S.
- Alhiniah M.H.
- Alelyani R.H.
- Badawi A.M.
- Alshahrani A.A.
- et al.
Acceptance of COVID-19 vaccine and associated factors among pregnant women in Saudi Arabia.
This attitude can be explained by women's sense of responsibility to protect the health of their fetuses and newborns during pregnancy and breastfeeding in the absence of evidence of the safety of the new, rapidly developed vaccines such as those against COVID-19.
12- Wilson R.J.
- Paterson P.
- Jarrett C.
- Larson H.J.
- et al.
Understanding factors influencing vaccination acceptance during pregnancy globally: a literature review.
Therefore, the risk of harming children's health during pregnancy and breastfeeding, and the lack of reliable data on vaccination of this vulnerable segment of the population are considered determinants of non-adherence to COVID-19 vaccination. In contrast, the vaccination prevalence rate among participants who received at least the first dose during the survey period was 61.8%.
Concerning the perceptions of the unvaccinated regarding intention to be vaccinated against COVID-19 in the future, when the unvaccinated (175 participants) were asked if they would be willing to be vaccinated, the results showed that 64% of them expressed willingness to be vaccinated. In comparison with other studies, this result was almost similar in six European countries where 60–70% of pregnant and lactating women expressed willingness to be vaccinated.
13Vaccine willingness and impact of the COVID-19 pandemic on women's perinatal experiences and practices—a multinational, cross-sectional study covering the first wave of the pandemic.
However, nearly half of the participants who changed their minds about vaccination (47.3%) made that choice just to have the vaccination pass required by the public authorities to be able to carry out normal activities of daily life. Vaccine pass possession can be included in the Compliance component, which is one of the most significant determinants of psychological readiness for vaccination acceptance.
14M. Geiger et al., « Measuring the 7Cs of vaccination readiness. », Eur J Psychol Assess, 20210715, doi: 10.1027/1015-5759/a000663.
Indeed, our finding is consistent with other studies that have indicated that vaccination can be accepted when it is considered a requirement to get free movement and access to public facilities and spaces.
15- Moccia G.
- Carpinelli L.
- Savarese G.
- De Caro F.
- et al.
Vaccine hesitancy and the green digital pass: a study on adherence to the Italian COVID-19 vaccination campaign.
Lastly, although two thirds of the unvaccinated (60.3%) who confirmed their categorical refusal of vaccination justified this behavior by the lack of information on the safety and security of vaccines against COVID-19, this result is considered lower than that reported in the Czech Republic (82.4%).
16COVID-19 vaccine acceptance of pregnant and lactating women (PLW) in Czechia: an analytical cross-sectional study.
The result of the univariate analysis showed a significant association between adherence to vaccination and place of Residence, education level of the couples, previous history of gestational diabetes, monthly household income of the participants, and age of their last child. This association was consistent with the results of other studies.
17Willingness to receive COVID-19 vaccine and its determinant factors among lactating mothers in Ethiopia: a cross-sectional study.
,18Women's views on accepting COVID-19 vaccination during and after pregnancy, and for their babies: a multi-methods study in the UK.
However, there are other studies that have invalidated this association with antecedent gestational diabetes.
19M. K. Kiefer et al., « Characteristics and perceptions associated with COVID-19 vaccination hesitancy among pregnant and postpartum individuals: a cross-sectional study », BJOG An Int J Obstet Gynaecol, vol. n/a, no n/a, doi: 10.1111/1471-0528.17110.
An odds ratio (OR) greater than 1 indicates positive adherence to vaccination, while an odds ratio less than 1 indicates the opposite attitude towards vaccination acceptance.
In the multivariate analysis, the predictive determinants for low adherence to vaccination were monthly household income above $282 (middle or high income) and lack of medical coverage. This result was in line with the results of other studies that have confirmed our findings regarding the lack of medical coverage
20C. Nicastri et al., P. Kumar, « Psychosocial, economic, and mental health predictors of COVID-19 vaccine intent ». PsyArXiv, 10 février 2022. doi: 10.31234/osf.io/snrgf.
, 21The association of social factors and health insurance coverage with COVID-19 vaccinations and hesitancy, july 2021.
, 22« Correlates and Disparities of COVID-19 Vaccine Hesitancy », Social Science Research Network.
as one of the limiting factors for adherence to COVID-19 vaccination.
Nevertheless, this finding was found to be inconsistent with the results of other studies
18Women's views on accepting COVID-19 vaccination during and after pregnancy, and for their babies: a multi-methods study in the UK.
,23- Ruiz J.B.
- Bell R.A.
- et al.
Predictors of intention to vaccinate against COVID-19: results of a nationwide survey.
which have reported that participants with average or high monthly incomes are more likely to accept vaccination than those with low incomes. Similarly, our result was opposed to that of Miranda K. Kiefer,
19M. K. Kiefer et al., « Characteristics and perceptions associated with COVID-19 vaccination hesitancy among pregnant and postpartum individuals: a cross-sectional study », BJOG An Int J Obstet Gynaecol, vol. n/a, no n/a, doi: 10.1111/1471-0528.17110.
who found that having medical coverage was one of the factors for hesitancy and refusal of vaccination.
On the other hand, having a child older than 6 months and not having gestational diabetes were considered positive factors for adherence to vaccination. This result may be explained by the reduced sense of risk to their children's health that mothers may feel as their children advance in age and do not rely solely on breastfeeding for nutrition, and as they develop immunity to disease as they grow older.
In our study, women who had gestational diabetes were the least likely to adhere to vaccination compared to those who did not. This finding contradicts other study that found that participants who had gestational diabetes were the most accepting of the vaccination.
11- Ghamri R.A.
- Othman S.S.
- Alhiniah M.H.
- Alelyani R.H.
- Badawi A.M.
- Alshahrani A.A.
- et al.
Acceptance of COVID-19 vaccine and associated factors among pregnant women in Saudi Arabia.
This attitude can be related to the fear of worsening their clinical condition during pregnancy due to lack of awareness or information. Nevertheless, studies have shown that gestational diabetes increases the risk of getting COVID-19 and that vaccination against COVID-19 has been shown to have no adverse effect on ongoing pregnancy.
24Gestational diabetes mellitus: a risk factor for COVID-19.
,25- Dick A.
- Rosenbloom J.I.
- Gutman-Ido E.
- Lessans N.
- Cahen-Peretz A.
- Chill H.H.
- et al.
Safety of SARS-CoV-2 vaccination during pregnancy- obstetric outcomes from a large cohort study.
This study allowed us to make an initial diagnosis of the status of vaccination against COVID-19 among pregnant women and women with infants in Morocco, to reveal that adherence to vaccination was largely associated with the vaccination pass required by the authorities, while refusal was overwhelmingly justified by the lack of reliable data on vaccine safety and efficacy. In addition, factors such as income, medical coverage, history of gestational diabetes, and age of last child emerged as determinants of vaccine adherence.
4.1 Limitation of the study
Our study faced some limits. First, because of the fact that only few studies have reported the prevalence of effective vaccination among pregnant and lactating women, or those whose last delivery was less than two years ago, the results of univariate and multivariate analyses were compared with studies exploring the intention to vaccinate in that particular population. Participants with a positive attitude towards vaccination were considered as if they were vaccinated, and those with a negative attitude were considered as if they were unvaccinated. Secondly, the cross-sectional study we conducted does not allow us to establish cause-effect relationship.
Article info
Publication history
Published online: January 28, 2023
Accepted:
January 21,
2023
Received in revised form:
January 16,
2023
Received:
June 22,
2022
Copyright
© 2023 The Authors. Published by Elsevier B.V. on behalf of INDIACLEN.